• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经内分泌肿瘤心脏转移:SSTR PET/CT 和心脏 MRI 的互补作用。

Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI.

机构信息

Department of Nuclear Medicine & Specialised PET Services, Royal Brisbane and Women's Hospital, Brisbane, QLD, 4006, Australia.

Faculty of Medicine, University of Queensland, Brisbane, Australia.

出版信息

J Nucl Cardiol. 2023 Dec;30(6):2676-2691. doi: 10.1007/s12350-023-03345-w. Epub 2023 Aug 16.

DOI:10.1007/s12350-023-03345-w
PMID:37587328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10682059/
Abstract

BACKGROUND

Cardiac metastases from neuroendocrine neoplasms (NENs) are being detected with increasing frequency, although the optimal imaging strategy remains unclear. We performed a single-center retrospective study to explore the role of somatostatin receptor positron emission tomography/computed tomography (SSTR PET/CT) and cardiac magnetic resonance imaging (CMR) in NEN cardiac metastases, determine the degree of concordance between the findings of these imaging modalities, and examine the advantages and disadvantages of each imaging technique. A secondary aim was to determine if cardiac metastases were associated with adverse cardiac events during peptide receptor radionuclide therapy (PRRT).

METHODS AND RESULTS

19 patients with NEN cardiac metastases were identified. A retrospective review of electronic medical records was performed, and if available SSTR PET/CT and CMR were blindly re-reviewed by imaging specialists, documenting the number and location of cardiac metastases. All 19 patients had SSTR PET/CT, and 10/19 patients had CMR. SSTR PET/CT identified more metastases than CMR. When identified on CMR, metastases were more accurately localized. 12/19 patients received PRRT, with no cardiac adverse effects.

CONCLUSION

SSTR PET/CT and CMR are complementary investigations in the imaging of NEN cardiac metastases. SSTR PET/CT appears more sensitive for lesion detection, and CMR offers better lesion characterization. Both investigations present useful information for the planning of treatment including PRRT, which was administered safely.

摘要

背景

神经内分泌肿瘤(NEN)的心脏转移的检出率越来越高,但最佳的影像学策略仍不清楚。我们进行了一项单中心回顾性研究,以探讨生长抑素受体正电子发射断层扫描/计算机断层扫描(SSTR PET/CT)和心脏磁共振成像(CMR)在 NEN 心脏转移中的作用,确定这些影像学方法的结果的一致性程度,并检查每种影像学技术的优缺点。次要目的是确定心脏转移是否与肽受体放射性核素治疗(PRRT)期间的不良心脏事件有关。

方法和结果

确定了 19 例 NEN 心脏转移患者。对电子病历进行回顾性审查,如果有 SSTR PET/CT 和 CMR,则由影像学专家对其进行盲法重新审查,记录心脏转移的数量和位置。所有 19 例患者均进行了 SSTR PET/CT 检查,10/19 例患者进行了 CMR 检查。SSTR PET/CT 比 CMR 检测到更多的转移灶。在 CMR 上发现的转移灶更准确地定位。19 例患者中有 12 例接受了 PRRT,无心脏不良事件。

结论

SSTR PET/CT 和 CMR 是 NEN 心脏转移的影像学检查的互补方法。SSTR PET/CT 对病灶检测更敏感,而 CMR 对病灶特征更有帮助。这两种检查都为治疗计划提供了有用的信息,包括安全进行的 PRRT。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c06/10682059/268bf9ba3bae/12350_2023_3345_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c06/10682059/13780a6c38e3/12350_2023_3345_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c06/10682059/b52997d627d4/12350_2023_3345_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c06/10682059/db1d7a0b7aac/12350_2023_3345_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c06/10682059/d7bdb8c92ee5/12350_2023_3345_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c06/10682059/268bf9ba3bae/12350_2023_3345_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c06/10682059/13780a6c38e3/12350_2023_3345_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c06/10682059/b52997d627d4/12350_2023_3345_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c06/10682059/db1d7a0b7aac/12350_2023_3345_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c06/10682059/d7bdb8c92ee5/12350_2023_3345_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c06/10682059/268bf9ba3bae/12350_2023_3345_Fig5_HTML.jpg

相似文献

1
Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI.神经内分泌肿瘤心脏转移:SSTR PET/CT 和心脏 MRI 的互补作用。
J Nucl Cardiol. 2023 Dec;30(6):2676-2691. doi: 10.1007/s12350-023-03345-w. Epub 2023 Aug 16.
2
Neuroendocrine Tumors: Diagnostics.神经内分泌肿瘤:诊断学
PET Clin. 2024 Jul;19(3):325-339. doi: 10.1016/j.cpet.2024.03.008. Epub 2024 May 6.
3
Prognostic Value of F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy.F-FDG PET/CT 在接受肽受体放射性核素治疗的晚期转移性神经内分泌肿瘤患者中的大型队列中的预后价值。
J Nucl Med. 2020 Nov;61(11):1560-1569. doi: 10.2967/jnumed.119.241414. Epub 2020 Mar 13.
4
PET/MRI imaging in neuroendocrine neoplasm.正电子发射断层扫描/磁共振成像在神经内分泌肿瘤中的应用。
Abdom Radiol (NY). 2023 Dec;48(12):3585-3600. doi: 10.1007/s00261-022-03757-1. Epub 2022 Dec 16.
5
Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI.基于生长抑素受体的PET/CT在疑似心脏结节病患者中的应用:与心脏MRI的初步比较
Oncotarget. 2016 Nov 22;7(47):77807-77814. doi: 10.18632/oncotarget.12799.
6
Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.《3 级神经内分泌肿瘤的肽受体放射性核素治疗:69 例患者的安全性和生存分析》
J Nucl Med. 2019 Mar;60(3):377-385. doi: 10.2967/jnumed.118.215848. Epub 2018 Aug 16.
7
NEN - the role of somatostatin receptor scintigraphy in clinical setting.神经内分泌肿瘤——生长抑素受体闪烁扫描术在临床中的作用
Nucl Med Rev Cent East Eur. 2016;19(2):118-25. doi: 10.5603/NMR.2016.0023.
8
Visual and whole-body quantitative analyses of  Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with Lu-DOTATATE.镓- DOTATATE PET/CT 的视觉和全身定量分析对 Lu-DOTATATE PRRT 后结局的预后评估。
Ann Nucl Med. 2024 Apr;38(4):296-304. doi: 10.1007/s12149-023-01899-w. Epub 2024 Jan 22.
9
Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease.生长抑素受体PET/CT在不同疾病阶段的MEN1患者中的价值。
J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2056-e2064. doi: 10.1210/clinem/dgab891.
10
State-of-the-Art Hybrid Imaging of Neuroendocrine Neoplasms.神经内分泌肿瘤的最新混合成像技术
J Comput Assist Tomogr. 2024;48(4):510-520. doi: 10.1097/RCT.0000000000001594. Epub 2024 Mar 22.

引用本文的文献

1
Detection of cardiac neuroendocrine tumour metastases by somatostatin receptor PET/CT: a systematic review and meta-analysis.生长抑素受体PET/CT检测心脏神经内分泌肿瘤转移:一项系统评价和荟萃分析。
Front Med (Lausanne). 2024 Oct 15;11:1491181. doi: 10.3389/fmed.2024.1491181. eCollection 2024.

本文引用的文献

1
Hybrid imaging of neuroendocrine tumors in the heart: Union is strength.心脏神经内分泌肿瘤的混合成像:团结就是力量。
J Nucl Cardiol. 2023 Feb;30(1):298-312. doi: 10.1007/s12350-021-02804-6. Epub 2021 Oct 7.
2
Case Report: Neuroendocrine Tumor With Cardiac Metastasis.病例报告:伴有心脏转移的神经内分泌肿瘤
Front Cardiovasc Med. 2020 Dec 4;7:596921. doi: 10.3389/fcvm.2020.596921. eCollection 2020.
3
The Use of Peptide Receptor Radionuclide Therapy in Patients With Neuroendocrine Tumor Cardiac Metastases.肽受体放射性核素疗法在神经内分泌肿瘤心脏转移患者中的应用。
Clin Nucl Med. 2021 Jan;46(1):e23-e26. doi: 10.1097/RLU.0000000000003283.
4
Cardiac Metastases in Patients with Neuroendocrine Tumours: Clinical Features, Therapy Outcomes, and Prognostic Implications.神经内分泌肿瘤患者的心脏转移:临床特征、治疗结果和预后意义。
Neuroendocrinology. 2021;111(10):907-924. doi: 10.1159/000510444. Epub 2020 Jul 27.
5
Cardiac Metastases in Neuroendocrine Tumors: 68Ga-DOTATATE PET/CT With Cardiac Magnetic Resonance Correlation.神经内分泌肿瘤心脏转移:68Ga-DOTATATE PET/CT 与心脏磁共振的相关性。
Clin Nucl Med. 2020 Apr;45(4):e201-e205. doi: 10.1097/RLU.0000000000002944.
6
Cardiac Magnetic Resonance for Diagnosis of Neuroendocrine Tumor Metastases to the Right and Left Ventricles with Carcinoid Heart Disease.心脏磁共振成像用于诊断类癌性心脏病导致的神经内分泌肿瘤转移至左右心室。
Case Rep Cardiol. 2019 Dec 5;2019:8746413. doi: 10.1155/2019/8746413. eCollection 2019.
7
Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia.澳大利亚昆士兰州三十年来神经内分泌肿瘤的流行病学趋势。
Cancer Epidemiol. 2019 Dec;63:101598. doi: 10.1016/j.canep.2019.101598. Epub 2019 Sep 17.
8
Solitary neuroendocrine carcinoma of the heart: a case report.心脏孤立性神经内分泌癌:一例报告
Eur Heart J Case Rep. 2018 Sep 12;2(3):yty096. doi: 10.1093/ehjcr/yty096. eCollection 2018 Sep.
9
Assessment of Cardiac Masses by Cardiac Magnetic Resonance Imaging: Histological Correlation and Clinical Outcomes.心脏磁共振成像评估心脏质量:组织学相关性和临床结局。
J Am Heart Assoc. 2019 Jan 8;8(1):e007829. doi: 10.1161/JAHA.117.007829.
10
Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT.使用 68Ga-DOTATATE PET-CT 鉴定和描述神经内分泌肿瘤患者的心肌转移。
Cancer Imaging. 2018 Sep 20;18(1):34. doi: 10.1186/s40644-018-0168-2.